Histamine synergistically promotes bFGF-induced angiogenesis by enhancing VEGF production via H1 receptor

Journal of Cellular Biochemistry

Volumn 114, Issue 5, 2013, Pages 1009-1019

  Lu, Qian ^a   Wang, Chong ^a   Pan, Rong ^a   Gao, Xinghua ^a   Wei, Zhifeng ^a   Xia, Yufeng ^a   Dai, Yue ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

angiogenesis; basic fibroblast growth factor; histamine; synergistic action

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CIMETIDINE; DIPHENHYDRAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HISTAMINE; HISTAMINE H1 RECEPTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; PROSTAGLANDIN SYNTHASE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT;

ANIMALS; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; HISTAMINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; NITRIC OXIDE SYNTHASE; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H1; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875160736     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24440     Document Type: Article

References (41)

1. Arai Y, Marui A, Komeda M,. 2006. Regenerative medicine with the sustained release system of basic fibroblast growth factor. Nippon Rinsho 64: 2142-2147.
2. Bao YL, Tsuchida K, Liu B, Kurisaki A, Matsuzaki T, Sugino H,. 2005. Synergistic activity of activin A and basic fibroblast growth factor on tyrosine hydroxylase expression through Smad3 and ERK1/ERK2 MAPK signaling pathways. J Endocrinal 184: 493-504.
3. Bello G, Cailotto F, Hanriot D, Kolopp-Sarda MN, Latger-Cannard V, Hess K, Zannad F, Longrois D, Ropars A,. 2008. C-reaction protein (CRP) increases VEGF-A expression in monocytic via a PI3-kinase and ERK 1/2 signaling dependent way. Atherosclerosis 200: 286-293.
4. Bouïs D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA,. 2006. A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53: 89-103.
5. Crivellato E, Nico B, Ribatti D,. 2008. Mast cells and tumour angiogenesis: New insight from experimental carcinogenesis. Cancer Lett 269: 1-6.
6. De Luisi A, Mangialardi G, Ria R, Acuto G, Ribatti D, Vacca A,. 2009. Anti-angiogenic activity of carebastine: A plausible mechanism affecting airway remodeling. Eur Respir J 34: 958-966.
7. Flati V, Pastore LI, Griffioen AW, Satijn S, Toniato E, D'Alimonte I, Laglia E, Marchetti P, Gulino A, Martinotti S,. 2006. Endothelial cell energy is mediated by bFGF through the sustained activation of p38-MAPK and NF-κB inhibition. Int J Immunopathol Pharmacol 19: 761-773.
8. Frewin DB, Cleland LG, Jonsson JR, Robertson PW,. 1986. Histamine levels in human synovial fluid. J Rheumatol 13: 13-14.
9. Gardner AM, Johnson GL,. 1996. Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated kinase. J Biol Chem 271: 14560-14566.
10. Garrabrant T, Tuman RW, Ludovici D, Tominovich R, Simoneaux RL, Galemmo RA, Jr., Johnson DL,. 2004. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2). Angiogenesis 7: 91-96.
11. Ghosh AK, Hirasawa N, Ohuchi K,. 2001. Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors. Br J Pharmacol 134: 1419-1428.
12. Holden NS, Gong W, King EM, Kaur M, Giembycz MA, Newton R,. 2007. Potentiation of NF-κB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells. Br J Pharmacol 152: 891-902.
13. Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL,. 2002. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (taxotere): Association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 1: 1191-1200.
14. Hynes NE, Dey JH,. 2010. Potential for targeting the fibroblast growth factor receptors in breast cancer. Cancer Res 70: 5199-5202.
15. Jeon O, Hwang KC, Yoo KJ, Kim BS,. 2006. Combined sustained delivery of basic fibroblast growth factor and administration of granulocyte colony-stimulating factor: Synergistic effect on angiogenesis in mouse ischemic limbs. J Endovasc Ther 13: 175-181.
16. Keogh RJ, Houliston RA, Wheeler-Jones CP,. 2002. Thrombin-stimulated Pyk2 phosphorylation in human endothelium is dependent on intracellular calcium and independent of protein kinase C and Src kinases. Biochem Biophys Res Commun 294: 1001-1008.
17. Kim S, Hagemann A, DeMichele A,. 2009. Immuno-modulatory gene polymorphisms and outcome in breast and ovarian cancer. Immunol Invest 38: 324-340.
18. Kubecova M, Kolostova K, Pinterova D, Kacprzak G, Bobek V,. 2011. Cimedidine: An anticancer drug? Eur J Pharm Sci 42: 439-444.
19. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K,. 2000. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6: 1004-1010.
20. Kwon JS, Kim YS, Cho AS, Cho HH, Kim JS, Hong MH, Jeong SY, Jeong MH, Cho JG, Park JC, Kang JC, Ahn Y,. 2011. The novel role of mast cells in the microenvironment of acute myocardial infarction. J Mol Cell Cardiol 50: 814-825.
21. Li H, Burkhardt C, Heinrich UR, Brausch I, Xia N, Förstermann U,. 2003. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation 107: 2348-2354.
22. Li Y, Chi L, Stechschulte DJ, Dileepan KN,. 2001. Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha. Microvasc Res 61: 253-262.
23. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, Clowes AW,. 2005. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res 96: 172-179.
24. Muñoz-Chápuli R, Quesada AR, Angel Medina M,. 2004. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61: 2224-2243.
25. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA,. 1998. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152: 1445-1452.
26. Nugent MA, Iozzo RV,. 2000. Fibroblast growth factors-2. Int J Biochem Cell Biol 32: 115-120.
27. Pap T, Distler O,. 2005. Linking angiogenesis to bone destruction in arthritis. Arthritis Rheum 52: 1346-1348.
28. Panet R, Eliash M, Atlan H,. 2006. Na+/K+/Cl-cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK. J Cell Physiol 206: 578-585.
29. Pin AL, Houle F, Guillonneau M, Paquet ER, Simard MJ, Huot J,. 2012. miR-20a represses endothelial cell migration by targeting MKK3 and inhibiting p38 MAP kinase activation in response to VEGF. Angiogenesis Epub ahead of print.
30. Qian RZ, Yue F, Zhang GP, Hou LK, Wang XH, Jin HM,. 2008. Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor. Chin Med J (Engl) 121: 2599-2603.
31. Sato Y,. 2006. Update on endogenous inhibitors of angiogenesis. Endothelium 13: 147-155.
32. Shahrara S, Volin MV, Connors MA, Haines GK, Koch AE,. 2002. Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 4: 201-208.
33. Tabruyn SP, Griffioen AW,. 2007. Molecular pathways of angiogenesis inhibition. Biochem Biophy Res Commun 355: 1-5.
34. Talreja J, Kabir MH, Filla M B, Stechschulte DJ, Dileepan KN,. 2004. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 113: 224-233.
35. Tan X, Essengue S, Talreja J, Reese J, Stechschulte DJ, Dileepan KN,. 2007. Histamine directly and synergistically with lipopolysaccharide stimulates cyclooxygenase-2 expression and prostaglandin I2 and E2 production in human coronary artery endothelial cells. J Immumol 179: 7899-7906.
36. Thurmond RL, Gelfand EW, Dunford PJ,. 2008. The role of histamine H1 and H4 receptors in allergic inflammation: The search for new antihistamines. Nat Rev Drug Discov 7: 41-53.
37. Tong Q, Zheng L, Lin L, Li B, Wang D, Huang C, Li D,. 2006. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway. Respir Res 2: 37.
38. Tsai AC, Pan SL, Liao CH, Guh JH, Wang SW, Sun HL, Liu YN, Chen CC, Shen CC, Chang YL, Teng CM,. 2010. Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo. Cancer Lett 292: 163-170.
39. Wu Y, Zhou BP,. 2009. Inflammation: A driving force speeds cancer metastasis. Cell Cycle 8: 3267-3273.
40. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H,. 2002. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology 35: 834-842.
41. Yue F, Zhang GP, Jin HM,. 2006. Effects of basic fibroblast growth factor on the expressions of angiogenic gene profile and cyclooxygenase-2 in brain microvascular endothelial cells. Sheng Li Xue Bao 58: 124-128.